Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

244 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Completed

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

NCT00428220

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +62 more
Locations
  • Emory University, Winship Cancer Institute Atlanta, Georgia, United States
  • Investigational Drug Service Atlanta, Georgia, United States
  • The Emory Clinic Atlanta, Georgia, United States
  • Loyola University Medical Center Maywood, Illinois, United States
View all 113 locations
View Trial Details
Completed

A Study of Sunitinib In Young Patients With Advanced Gastrointestinal Stromal Tumor

NCT01396148

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Children's Center for Cancer and Blood Diseases, Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital Boston Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Fakultni nemocnice Brno Brno, Czechia
View Trial Details
Completed

Trial of Dasatinib in Advanced Sarcomas

NCT00464620

Conditions
Chondrosarcoma, Chordoma, Digestive System Diseases, +37 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • City of Hope Duarte, California, United States
  • Cedars-Sinai Outpatient Cancer Center Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 20 locations
View Trial Details
Completed

Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

NCT01560260

Conditions
Abnormalities, Multiple, Cardiovascular Diseases, Carney Complex, +25 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Dana-Farber/Harvard Cancer Center Boston, Massachusetts, United States
View Trial Details

Related conditions